Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Prothrombin Complex Concentrates Market Outlook

The global prothrombin complex concentrates market is expected to be valued at US$ 772.0 million in 2023 and reach a valuation of US$ 1.2 billion by 2033. The demand for prothrombin complex concentrates is estimated to record a steady CAGR of 4.1%, with the United Kingdom, the United States., China, and India emerging as key producers.

In the prothrombin complex concentrates market, there is a growing focus on improving patient safety, with many companies aiming to create safer and more efficient products that have fewer side effects. This trend has resulted in the development of novel prothrombin complex concentrates products such as non-activated prothrombin complex concentrates and recombinant factor VIII products, which have proven to be more effective.

Personalized medicine is a growing trend in the prothrombin complex concentrates market, and companies are developing tailored products to address individual patient needs. This includes products made specifically for patients with different bleeding diseases and precision medications that aim to treat particular genetic abnormalities. There is also a trend toward the development of innovative delivery methods for prothrombin complex concentrates, such as subcutaneous and intranasal delivery systems. These methods are preferred because they are more convenient and can enhance patient adherence to treatment.

To increase efficiency in prothrombin complex concentrates production and distribution, many companies are utilizing data analytics and digital technologies, including predictive analytics, to forecast demand, and digital tools to optimize supply chain management.

The potential for blood clots in prothrombin concentrate complex is one of the key factors limiting market growth. Blood clots can cause problems like venous thromboembolism, microvascular thrombosis, Disseminated Intravascular Coagulation (DIC), and myocardial infarction. A market study called "Thromboembolic Events after Vitamin K Antagonist Reversal with 4-Factor Prothrombin Complex Concentrate" found that 7.3% of patients who got 4-factor- prothrombin complex concentrates had thromboembolic events. Also, according to the UPMC System Pharmacy and Therapeutics Committee Formulary Evaluation, 2.9% of Kcentra users experienced thromboembolic events after using the medication. This raises safety concerns about employing factor IX complex goods, which is expected to probably impede the market.

Attributes Details
Prothrombin Complex Concentrates Market CAGR (2023 to 2033) 4.1%
Prothrombin Complex Concentrates Market Size (2023) US$ 772.0 million
Prothrombin Complex Concentrates Market Size (2033) US$ 1.2 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What is the Prothrombin Complex Concentrates Future Outlook Compared to Historical Outlook?

The global demand for prothrombin complex concentrates recorded a CAGR of 4.4% between 2018 and 2022, and it's expected to record a CAGR of 4.1% between 2023 and 2033. The market's growth potential could be looked at from short-term, mid-term, and long-term perspectives.

Short Term Outlook (2023 to 2025) As the global incidence of bleeding disorders continues to rise, there is a growing demand for effective and safe treatments. Prothrombin complex concentrates are becoming increasingly popular due to their ability to quickly reverse the effects of anticoagulant therapy, making them a valuable treatment option for patients with coagulation disorders.
Mid Term Outlook (2025 to 2028 ) Many companies are investing in research and development to create prothrombin complex concentrates and improve the efficacy and safety of existing products. This investment is expected to lead to the development of new treatments and an expansion of the market.
Long Term Outlook (2028 to 2032 ) The increasing availability of healthcare infrastructure in emerging markets such as India and China is creating growth opportunities for prothrombin complex concentrates. The approval of new prothrombin complex concentrates products in these markets can lead to significant growth for manufacturers.

Using Warfarin to Expand the Market Swiftly

Warfarin has become the most common oral anticoagulant for people with thrombosis. Anti-thrombotic medicine sales, including warfarin, account for around 3% of all drug sales globally and are anticipated to increase.

Fresh frozen plasma (FFP) and other therapies like it can't compete with Prothrombin Complex Concentrate.

A transfusion reaction and volume overload can occur when FFP and other therapies are used. Also, FFP is rarely able to bring the INR back to normal. Prothrombin complex concentrate, on the other hand, is an effective way to normalize the INR and reduce the risk of pathogen transmission.

Problems with clotting caused by Prothrombin Complex Concentrate

Blood clots can happen when prothrombin complex concentrate is given, leading to microvascular thrombosis, disseminated intravascular coagulation, and myocardial infarction. Underlying illnesses, excessive dosages of prothrombin complex concentrate, and unbalanced ingredients can all increase the risk of thrombotic problems.

Unmet Hemophilia Therapeutic Needs and Growing Geriatric Population

As the requirement for anticoagulation therapy with oral anticoagulants is increasing amongst the geriatric population, the need to reverse anticoagulation in adverse conditions is also increasing. Thus, the growing geriatric population is expected to fuel the growth of the prothrombin complex concentrates market over the forecast period.

The worldwide incidence of hemophilia is not well known; however, it has been estimated that more than 400,000 people have hemophilia. 75% of people with hemophilia have been estimated to receive inadequate treatment or have no access to treatment.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

80% Revenue Contribution by Leading Manufacturers in Prothrombin Complex Concentrates Market

The prothrombin complex concentrates global manufacturers mainly dominate the market. The manufacturers of prothrombin complex concentrates are competing based on the adoption of prothrombin complex concentrates. The growing demand for optimized & sustainable healthcare has created immense growth opportunities for global manufacturers.

Companies such as Shire, Octapharma AG, and CSL Behring GmbH hold approximately 80% revenue share in the global prothrombin complex concentrates market. Also, companies operating in the market are collaborating with retailers and local distributors to increase the penetration of prothrombin complex concentrates.

Comparative View of Prothrombin Complex Concentrates Market

Prothrombin Complex Concentrates Market:

Attributes Prothrombin Complex Concentrates Market
CAGR (2023 to 2033) 4.1%
Market Value (2033) US$ 1.2 billion
Growth Factor Regulatory bodies are giving more product approvals.
Opportunity Hemophilia B is becoming more common.
Restraint PCC-related thrombotic complication

Anticoagulant Reversal Drugs Market:

Attributes Anticoagulant Reversal Drugs Market
CAGR (2023 to 2033) 14.9%
Market Value (2033) US$ 4571.40 million
Growth Factor Acquisitions and mergers are getting more attention.
Opportunity More and more people with blood problems need anticoagulants in case of uncontrolled bleeding.
Restraint High cost of drugs that stop blood from clotting

Clostridioides Difficile Infection Treatment Market:

Attributes Clostridioides Difficile Infection Treatment Market
CAGR (2023 to 2033) 7.1%
Market Value (2033) US$ 1777.61 million
Growth Factor Clostridioides difficile is becoming more common.
Opportunity Key players in preventing clostridioides difficile infections should do more research and development.
Restraint Huge investments are required for drug development

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Why is China Considered to be a Lucrative Prothrombin Complex Concentrates Market?

According to the discussions held with key opinion leaders in the prothrombin complex concentrates market, substantial growth has been witnessed in the China market for prothrombin complex concentrates. Manufacturers operating in the China and APEC markets are estimated to have significant growth opportunities in the prothrombin complex concentrates market over the forecast period.

How is the United States Prothrombin Complex Concentrates Market Faring?

The United States prothrombin complex concentrates market is one of the significant and most established markets for prothrombin complex concentrates globally, and it continues to experience growth due to various factors.

One significant factor driving growth in the United States prothrombin complex concentrates market is the increasing incidence of bleeding disorders, such as hemophilia and von Willebrand disease. According to the Centers for Disease Control and Prevention (CDC), hemophilia affects approximately 20,000 people in the United States, while von Willebrand disease affects 1% of the United States population. As the incidence of these disorders continues to rise, the demand for prothrombin complex concentrates is also increasing.

The growing use of prothrombin complex concentrates in emergency medicine is another factor boosting market expansion in the United States. Prothrombin complex concentrates products are commonly used in emergencies to treat patients with acute bleeding or coagulation disorders. The availability of prothrombin complex concentrates in emergency departments, and trauma centers across the United States have led to a significant increase in demand for prothrombin complex concentrates.

Can India Become a Successful Market?

India has the potential to become a profitable market for prothrombin complex concentrates due to several factors, although challenges need to be addressed to achieve maximum potential. One of the significant factors that make India attractive is its significant population which results in a substantial number of patients with coagulation disorders, including an estimated 450,000 hemophilia patients, which is one of the maximum numbers globally.

The demand for prothrombin complex concentrates is expected to grow as bleeding disorders increase. India's healthcare infrastructure is another appealing factor that has improved due to the Indian government's various initiatives, leading to an increase in healthcare facilities, including specialized treatment centers for bleeding disorders.

Accessibility to prothrombin complex concentrates has improved, creating market growth opportunities. Also, due to the increasing awareness of bleeding disorders among patients and healthcare professionals, diagnosis and treatment rates have increased, creating a significant demand for prothrombin complex concentrates as patients and physicians seek more effective and safer treatment options.

Category-wise Insights

The market is expected to be led by the Hospitals & ASCs segment

Hospitals, outpatient surgical centers, specialized clinics, and other places make up the different segments of the market. For the next five years, the market's leadership is anticipated to rest with hospitals and the outpatient surgery segment. This results from the COVID-19 pandemic-related increase in the use of prothrombin complex concentrate, government recommendations, and hospital purchases of more plasma products. The specialty clinics segment is likely to grow because some multiple surgeons and clinics are privately owned.

The others segment, which includes urgent care centers, emergency trauma centers, doctors' offices, and so on, is likely to grow because the government and private players are investing more in improving healthcare facilities.

The section on acquired coagulation factor insufficiency is anticipated to grow as more warfarin-related bleeding incidents occur.

Based on its use, the market is divided into two categories: congenital and acquired coagulation factor deficiency. The most lucrative market in 2019 was for acquired coagulation factor deficiency, and in the coming years, it is anticipated to expand rapidly.

The segment is expected to grow because there are more cases of life-threatening bleeding linked to the use of warfarin, more cases of induced coagulation factor deficiency during surgery, and new products.

According to the Hemophilia Federation of America, there are about 29,000 cases of bleeding in the United States each year that are caused by taking warfarin. This is expected to make this market segment grow rapidly by 2027. The segment is also going to benefit significantly from the growing Kcentra sales brought on by the COVID-19 situation. On the other hand, government initiatives to find novel treatments for bleeding disorders like Hemophilia B are likely to benefit the congenital coagulation factor deficiency segment.

Competition Landscape

Companies are using various strategies to expand their market share. These include

  • Strategic partnerships and collaborations: Many companies are forming partnerships and collaborations with other companies to expand their market reach, develop new products, and improve their manufacturing capabilities. For example, in 2021, Sanquin and Octapharma entered into a long-term partnership to develop and manufacture prothrombin complex concentrates on treating bleeding disorders.
  • Product differentiation and innovation: Many companies focus on developing new and innovative prothrombin complex concentrates that offer better efficacy, safety, and patient convenience. For example, in 2020, CSL Behring received FDA approval for its Idelvion product, a longer-acting factor IX therapy that can be administered less frequently than traditional prothrombin complex concentrates.
  • Market expansion: Many companies focus on expanding their market reach into emerging markets such as India, China, and Latin America. For example, in 2020, Grifols opened a new plasma fractionation plant in China to increase its regional presence and expand its prothrombin complex concentrates product offerings.
  • Mergers and acquisitions: Many companies are using mergers and acquisitions to consolidate their position in the market, expand their product offerings, and gain access to new markets. For example, in 2021, Takeda announced its intention to acquire the biotech company, Maverick Therapeutics, to expand its oncology and hematology portfolios.

Key Segments

Distribution Channel:

  • Compound Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies

Region:

  • North America
  • Latin America
  • Europe
  • APEJ
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the Current Prothrombin Complex Concentrates Market Size in 2023?

The market is estimated to acquire US$ 772 million in 2023.

What Restrains the Prothrombin Complex Concentrates Market Growth?

PCC-related thrombotic complications restrain market growth.

What Fuels China’s Prothrombin Complex Concentrates Market?

Manufacturers operating in China increase significant growth opportunities in the market.

How is the United States Prothrombin Complex Concentrates Market Faring?

The increasing incidence of bleeding disorders raises the market.

What was the Last Four Years’ Growth Rate for Prothrombin Complex Concentrates?

The global market expanded at a CAGR of 4.4% between 2018 and 2022.

Table of Content

1. Executive Summary | Prothrombin Complex Concentrates Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. 3-Factor PCC

        5.3.2. 4-Factor PCC

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Treatment Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Treatment Type, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment Type, 2023 to 2033

        6.3.1. Haemorrhagic Episodes in Factor IX Defficiency - Haemiohilia B

        6.3.2. Trauma

        6.3.3. Life-Threatening Coagulopathy with Acute Bleeding

        6.3.4. Warfarin-Associated Acute Life Threatening Bleeding

        6.3.5. Non-Warfarin Anticoagulant Reversal with Acute Bleeding

    6.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Treatment Type, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033

        7.3.1. Compound Pharmacies

        7.3.2. Hospital Pharmacies

        7.3.3. Retail Pharmacies

    7.4. Y-o-Y Growth Trend Analysis By End User , 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. Asia Pacific Excluding Japan

        8.3.6. Japan

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Treatment Type

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Treatment Type

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Argentina

            10.2.1.4. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Treatment Type

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Treatment Type

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. France

            11.2.1.3. Italy

            11.2.1.4. Spain

            11.2.1.5. United kingdom

            11.2.1.6. Benelux

            11.2.1.7. Nordics

            11.2.1.8. Rest of Western Europe

        11.2.2. By Product Type

        11.2.3. By Treatment Type

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Treatment Type

        11.3.4. By End User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Rest of Eastern Europe

        12.2.2. By Product Type

        12.2.3. By Treatment Type

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Treatment Type

        12.3.4. By End User

    12.4. Key Takeaways

13. Asia Pacific Excluding Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. ASEAN

            13.2.1.3. Australia & New Zealand

            13.2.1.4. China

            13.2.1.5. Rest of Asia Pacific Excluding Japan

        13.2.2. By Product Type

        13.2.3. By Treatment Type

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Treatment Type

        13.3.4. By End User

    13.4. Key Takeaways

14. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

        14.2.2. By Product Type

        14.2.3. By Treatment Type

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Treatment Type

        14.3.4. By End User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. South Africa

            15.2.1.2. GCC Countries

            15.2.1.3. Rest of Middle East and Africa

        15.2.2. By Product Type

        15.2.3. By Treatment Type

        15.2.4. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Treatment Type

        15.3.4. By End User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Treatment Type

            16.1.2.3. By End User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Treatment Type

            16.2.2.3. By End User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Treatment Type

            16.3.2.3. By End User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Treatment Type

            16.4.2.3. By End User

    16.5. Argentina

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Treatment Type

            16.5.2.3. By End User

    16.6. Germany

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Treatment Type

            16.6.2.3. By End User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Treatment Type

            16.7.2.3. By End User

    16.8. Italy

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Treatment Type

            16.8.2.3. By End User

    16.9. Spain

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Treatment Type

            16.9.2.3. By End User

    16.10. United kingdom

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Treatment Type

            16.10.2.3. By End User

    16.11. Benelux

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Treatment Type

            16.11.2.3. By End User

    16.12. Nordics

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Treatment Type

            16.12.2.3. By End User

    16.13. Poland

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Treatment Type

            16.13.2.3. By End User

    16.14. Russia

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Treatment Type

            16.14.2.3. By End User

    16.15. India

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Treatment Type

            16.15.2.3. By End User

    16.16. ASEAN

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product Type

            16.16.2.2. By Treatment Type

            16.16.2.3. By End User

    16.17. Australia & New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product Type

            16.17.2.2. By Treatment Type

            16.17.2.3. By End User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product Type

            16.18.2.2. By Treatment Type

            16.18.2.3. By End User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product Type

            16.19.2.2. By Treatment Type

            16.19.2.3. By End User

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product Type

            16.20.2.2. By Treatment Type

            16.20.2.3. By End User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product Type

            16.21.2.2. By Treatment Type

            16.21.2.3. By End User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Treatment Type

        17.3.4. By End User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Shire

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Octapharma AG

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Takeda Pharmaceutical Company Limited

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Sanquin Blood Supply Foundation

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. CSL Behring GmbH

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Kedrion Biopharma Inc.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Grifols, S.A.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Treatment Type, 2017 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End User , 2017 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Treatment Type, 2017 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End User , 2017 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Treatment Type, 2017 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End User , 2017 to 2033

Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 14: Western Europe Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 15: Western Europe Market Value (US$ Million) Forecast by Treatment Type, 2017 to 2033

Table 16: Western Europe Market Value (US$ Million) Forecast by End User , 2017 to 2033

Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 18: Eastern Europe Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 19: Eastern Europe Market Value (US$ Million) Forecast by Treatment Type, 2017 to 2033

Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User , 2017 to 2033

Table 21: Asia Pacific Excluding Japan Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 22: Asia Pacific Excluding Japan Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 23: Asia Pacific Excluding Japan Market Value (US$ Million) Forecast by Treatment Type, 2017 to 2033

Table 24: Asia Pacific Excluding Japan Market Value (US$ Million) Forecast by End User , 2017 to 2033

Table 25: Japan Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 26: Japan Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 27: Japan Market Value (US$ Million) Forecast by Treatment Type, 2017 to 2033

Table 28: Japan Market Value (US$ Million) Forecast by End User , 2017 to 2033

Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2017 to 2033

Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Treatment Type, 2017 to 2033

Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End User , 2017 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End User , 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Treatment Type, 2017 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End User , 2017 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 17: Global Market Attractiveness by Product Type, 2023 to 2033

Figure 18: Global Market Attractiveness by Treatment Type, 2023 to 2033

Figure 19: Global Market Attractiveness by End User , 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End User , 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Treatment Type, 2017 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End User , 2017 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 37: North America Market Attractiveness by Product Type, 2023 to 2033

Figure 38: North America Market Attractiveness by Treatment Type, 2023 to 2033

Figure 39: North America Market Attractiveness by End User , 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End User , 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Treatment Type, 2017 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End User , 2017 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 57: Latin America Market Attractiveness by Product Type, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Treatment Type, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End User , 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Western Europe Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 62: Western Europe Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 63: Western Europe Market Value (US$ Million) by End User , 2023 to 2033

Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Western Europe Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 71: Western Europe Market Value (US$ Million) Analysis by Treatment Type, 2017 to 2033

Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 74: Western Europe Market Value (US$ Million) Analysis by End User , 2017 to 2033

Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 77: Western Europe Market Attractiveness by Product Type, 2023 to 2033

Figure 78: Western Europe Market Attractiveness by Treatment Type, 2023 to 2033

Figure 79: Western Europe Market Attractiveness by End User , 2023 to 2033

Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: Eastern Europe Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 82: Eastern Europe Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 83: Eastern Europe Market Value (US$ Million) by End User , 2023 to 2033

Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Treatment Type, 2017 to 2033

Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User , 2017 to 2033

Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 97: Eastern Europe Market Attractiveness by Product Type, 2023 to 2033

Figure 98: Eastern Europe Market Attractiveness by Treatment Type, 2023 to 2033

Figure 99: Eastern Europe Market Attractiveness by End User , 2023 to 2033

Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033

Figure 101: Asia Pacific Excluding Japan Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 102: Asia Pacific Excluding Japan Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 103: Asia Pacific Excluding Japan Market Value (US$ Million) by End User , 2023 to 2033

Figure 104: Asia Pacific Excluding Japan Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: Asia Pacific Excluding Japan Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 106: Asia Pacific Excluding Japan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: Asia Pacific Excluding Japan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: Asia Pacific Excluding Japan Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 109: Asia Pacific Excluding Japan Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 110: Asia Pacific Excluding Japan Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 111: Asia Pacific Excluding Japan Market Value (US$ Million) Analysis by Treatment Type, 2017 to 2033

Figure 112: Asia Pacific Excluding Japan Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 113: Asia Pacific Excluding Japan Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 114: Asia Pacific Excluding Japan Market Value (US$ Million) Analysis by End User , 2017 to 2033

Figure 115: Asia Pacific Excluding Japan Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 116: Asia Pacific Excluding Japan Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 117: Asia Pacific Excluding Japan Market Attractiveness by Product Type, 2023 to 2033

Figure 118: Asia Pacific Excluding Japan Market Attractiveness by Treatment Type, 2023 to 2033

Figure 119: Asia Pacific Excluding Japan Market Attractiveness by End User , 2023 to 2033

Figure 120: Asia Pacific Excluding Japan Market Attractiveness by Country, 2023 to 2033

Figure 121: Japan Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 122: Japan Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 123: Japan Market Value (US$ Million) by End User , 2023 to 2033

Figure 124: Japan Market Value (US$ Million) by Country, 2023 to 2033

Figure 125: Japan Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 126: Japan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: Japan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: Japan Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 129: Japan Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 130: Japan Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 131: Japan Market Value (US$ Million) Analysis by Treatment Type, 2017 to 2033

Figure 132: Japan Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 133: Japan Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 134: Japan Market Value (US$ Million) Analysis by End User , 2017 to 2033

Figure 135: Japan Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 136: Japan Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 137: Japan Market Attractiveness by Product Type, 2023 to 2033

Figure 138: Japan Market Attractiveness by Treatment Type, 2023 to 2033

Figure 139: Japan Market Attractiveness by End User , 2023 to 2033

Figure 140: Japan Market Attractiveness by Country, 2023 to 2033

Figure 141: Middle East and Africa Market Value (US$ Million) by Product Type, 2023 to 2033

Figure 142: Middle East and Africa Market Value (US$ Million) by Treatment Type, 2023 to 2033

Figure 143: Middle East and Africa Market Value (US$ Million) by End User , 2023 to 2033

Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2017 to 2033

Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Treatment Type, 2017 to 2033

Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033

Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033

Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End User , 2017 to 2033

Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 157: Middle East and Africa Market Attractiveness by Product Type, 2023 to 2033

Figure 158: Middle East and Africa Market Attractiveness by Treatment Type, 2023 to 2033

Figure 159: Middle East and Africa Market Attractiveness by End User , 2023 to 2033

Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Gene Therapy in CNS Disorder Market

Published : February 2023

Healthcare

Oncology Imaging Software Market

Published : February 2023

Explore Healthcare Insights

View Reports

Prothrombin Complex Concentrates Market